MARKET

SOLY

SOLY

SOLITON, INC.
NASDAQ

Real-time Quotes | Nasdaq Last Sale

8.40
-0.13
-1.52%
Opening 10:34 12/02 EST
OPEN
8.40
PREV CLOSE
8.53
HIGH
8.41
LOW
8.00
VOLUME
56.48K
TURNOVER
--
52 WEEK HIGH
15.50
52 WEEK LOW
5.69
MARKET CAP
178.00M
P/E (TTM)
-11.2420
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Akers Biosciences, Cidara Therapeutics leads healthcare gainers; Applied Therapeutics, Soliton among major losers
Gainers: Akers Biosciences (AKER) +45%, Cidara Therapeutics (CDTX) +29%, Five Prime Therapeutics (FPRX) +24%, Zhongchao (ZCMD) +22%, Vaxart (VXRT) +22%.Losers: Applied Therapeutics (APLT) -12%, Soliton (SOLY) -13%, Harmony Biosciences Holdings (HRMY) -10%, Can-Fite BioPharma (CANF) -10%, Oncternal Therapeutics (ONCT) -9%.
Seekingalpha · 11/12 16:04
Soliton Q3 EPS $(0.17), Inline
Soliton (NASDAQ:SOLY) reported quarterly losses of $(0.17) per share which met the analyst consensus estimate. This is a 37.04 percent increase over losses of $(0.27) per share from the same period last year.
Benzinga · 11/12 12:41
Soliton EPS in-line
Soliton (SOLY): Q3 GAAP EPS of -$0.17 in-line.Cash, cash equivalents and restricted cash of $34.8MPress Release
Seekingalpha · 11/12 12:31
Soliton, Inc. /Tx/ to Host Earnings Call
ACCESSWIRE · 11/12 11:45
Soliton names Brad A. Hauser as CEO
Soliton ([[SOLY]] +2.0%) announces the appointment of Brad A. Hauser as President and Chief Executive Officer.Mr. Hauser most recently served as Vice President, R&D and General Manager for CoolSculpting at
Seekingalpha · 11/02 15:13
Soliton Appoints Dr. Michael Kaminer to Board of Directors
Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology, today announced it has appointed Michael S. Kaminer, M.D. to Soliton's Board of Directors.
PR Newswire · 10/27 13:01
Soliton Appoints Niquette Hunt to Board of Directors
Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology, today announced the appointment of Niquette Hunt to its Board of Directors. Ms. Hunt currently serves as President and CEO of Candesant Biomedical.
PR Newswire · 10/22 13:01
We're Hopeful That Soliton (NASDAQ:SOLY) Will Use Its Cash Wisely
Simply Wall St. · 10/05 17:03
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of SOLY. Analyze the recent business situations of SOLITON, INC. through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average SOLY stock price target is 16.00 with a high estimate of 22.00 and a low estimate of 12.00.
EPS
Institutional Holdings
Institutions: 69
Institutional Holdings: 3.35M
% Owned: 15.80%
Shares Outstanding: 21.19M
TypeInstitutionsShares
Increased
16
99.04K
New
17
-860.82K
Decreased
10
198.58K
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
-0.14%
Healthcare Equipment & Supplies
-0.23%
Key Executives
Chairman/Co-Founder/Executive Director
Walter Klemp
President/Chief Executive Officer
Bradley Hauser
Vice Chairman/Chief Scientific Officer/Director
Christopher Capelli
Chief Financial Officer
Lori Bisson
Chief Operating Officer
Joe Tanner
Independent Director
Jonathan Foster
Independent Director
Danika Harrison
Independent Director
Niquette Hunt
Independent Director
Michael Kaminer
  • Dividends
  • Splits
  • Insider Activity
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About SOLY
Soliton Inc is an aesthetic medical device company. The Company develops a Rapid Acoustic Pulse (RAP) device that works in partnership with a short pulse laser for tattoo removal. The RAP device in coordination with the pulsed laser removes ink pigment from the macrophages. The device also enables multiple passes in a single treatment that makes tattoo removal possible in two to three laser treatments. The RAP device uses an acoustic wave technology that creates audio waves, and provides electronic wave shaping to reduce frequencies that cause heat and pain.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Soliton Inc stock information, including NASDAQ:SOLY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SOLY stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading SOLY stock methods without spending real money on the virtual paper trading platform.